Ticker
HRTXCompany Name
HERON THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Buyback Yield | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares |
---|---|---|---|
6/30/2025 | -0.63% | $ 202.35M | $ 1.28M |
3/31/2025 | -0.27% | $ 369.2M | $ 993K |
12/31/2024 | -0.3% | $ 312.28M | $ 940K |
9/30/2024 | -0.37% | $ 194.68M | $ 716K |
6/30/2024 | -7.45% | $ 404.95M | $ 30.15M |
3/31/2024 | -6.93% | $ 432.37M | $ 29.98M |
12/31/2023 | -8.39% | $ 354.78M | $ 29.76M |
9/30/2023 | -37.02% | $ 81.04M | $ 30M |
6/30/2023 | -35.52% | $ 212.55M | $ 75.49M |
3/31/2023 | -28.28% | $ 266.96M | $ 75.49M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity) / Market Cap
(=) Buyback Yield
Buyback Yield for HERON THERAPEUTICS INC is calculated as follows: (-1 * CF - Equity [ $ 168.47M ]) / Market Cap [ $ 1.57B ]
(=) Buyback Yield [ -10.75% ]
Minimum
Dec 31, 2022
Maximum
Jun 30, 2022
Average
Median
filtered constituents | 3.28K |
---|---|
min | -8.43% |
max | 8.46% |
average | 0.64% |
median | 0.01% |
std | 2.71% |